Relationship between adverse events and antiplatelet drug resistance in neurovascular intervention: a meta-analysis

@article{Shim2018RelationshipBA,
  title={Relationship between adverse events and antiplatelet drug resistance in neurovascular intervention: a meta-analysis},
  author={Eunjung Shim and Chang-Woo Ryu and Soonchan Park and Han Na Lee and Hee Sup Shin and Sang-beom Kim},
  journal={Journal of NeuroInterventional Surgery},
  year={2018},
  volume={10},
  pages={942 - 948}
}
Background This meta-analysis aimed to evaluate the association between antiplatelet resistance and the risk of procedure-related complications in neurovascular interventions. Methods We identified relevant articles by searching electronic databases and reviewed the reference lists of selected papers. The risk of adverse events between antiplatelet responders and hyporesponders during neurointervention was compared in eligible clinical studies. Risk ratios (RRs) and 95% CIs were pooled using a… 
Outcome of intracranial flow diversion according to the antiplatelet regimen used: a systematic review and meta-analysis
TLDR
Evidence suggests that dual antiplatelet regimens including ticagrelor or prasugrel are safe for patients undergoing flow diversion procedures.
Antiplatelet therapy for prevention of thromboembolic complications in coiling-only procedures for unruptured brain aneurysms
TLDR
Periprocedural antiplatelet therapy was associated with a low symptomatic thromboembolic event after coiling-only for unruptured aneurysms, however, available evidence is of limited quality with significant heterogeneity, requiring evidence from randomized controlled trials.
Utility of platelet function testing in stent-assisted coiling of cerebral aneurysms
  • M. Wirtz, C. Schirmer, C. Griessenauer
  • Medicine
    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
  • 2019
TLDR
In patients where the pharmacy-mediated antiplatelet protocol was followed, the thromboembolic complication rate was 1.8%.
Antithrombotic therapies for neurointerventional surgery: a 2021 French comprehensive national survey.
TLDR
An exhaustive cross-sectional overview of antithrombotic use in neurointerventional procedures in France is obtained through a nationwide survey, highlighting the important heterogeneity in clinical practices across centers.
Safety and efficacy of a pre-treatment antiplatelet regimen of unruptured intracranial aneurysms: a single-center experience
TLDR
The use of a high dosage antiplatelet premedication was safe and effective for the treatment of unruptured intracranial aneurysms with stent-assisted coiling or flow diverter stents and Mortality and morbidity rates compare favorably with the current literature.
The safety of triple antiplatelet therapy under thromboelastography guidance in patients undergoing stenting for ischemic cerebrovascular disease
TLDR
TAT under TEG guidance appears to be a safe antiplatelet strategy in patients undergoing stenting for extracranial and/or intracranial artery stenosis and favorable outcomes can be achieved in these patients.
A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery
TLDR
The presence of aspirin resistance in patients undergoing orthopaedic surgery may place patients at greater risk of thrombotic events if aspirin is prescribed for VTE prophylaxis, and this could further increase the risk of complications associated with VTE and potential long-term consequences such as post-thrombosis syndrome.
Platelet Function Assays for the Diagnosis of Aspirin Resistance
TLDR
Comparison of the most frequently used platelet assays to diagnose aspirin resistance, including the basic mechanism, methodology, reference ranges, inter-assay comparison, and their respective clinical considerations when using are compared.
Coil Embolization for Unruptured Intracranial Aneurysms at the Dawn of Stent Era: Results of the Japanese Registry of Neuroendovascular Therapy (JR-NET) 3
Endosaccular coiling is recognized as a feasible method for treating unruptured intracranial aneurysms (UIAs). We retrospectively reviewed cases of UIAs treated by coiling in the Japanese Registry of
Macrostachyols A-D, oligostilbenes from Gnetum macrostachyum inhibited in vitro human platelet aggregation
TLDR
It is suggested that oligostilbenes from this plant might be applied as antiplatelet aggregation agents in platelet hyperreactivity- related diseases.
...
1
2
...

References

SHOWING 1-10 OF 31 REFERENCES
Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis
TLDR
Patients who are resistant to aspirin are at a greater risk of clinically important cardiovascular morbidity long term than patients who are sensitive to aspirin.
Anti-platelet drug resistance in the prediction of thromboembolic complications after neurointervention.
TLDR
Identifying individuals with poor platelet inhibition using standard regimens is of great clinical importance and may help prevent cerebral ischemic events in the future.
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.
TLDR
Among patients treated with clopidogrel for percutaneous coronary intervention, carriage of even 1 reduced-function CYP2C19 allele appears to be associated with a significantly increased risk of major adverse cardiovascular events, particularly stent thrombosis.
Antiplatelet drug resistance did not increase the thromboembolic events after stent-assisted coiling of unruptured intracranial aneurysm: a single center experience of 99 cases
TLDR
Aspirin or clopidogrel resistance did not show significant relationships with acute and delayed TEs in the SAC of UIA, and without modification of antiplatelet medication, 4% of acute symptomatic TEs and 10% of delayedTEs were demonstrated.
Neurointerventional Stenting and Antiplatelet Function Testing: To Do or Not to Do?
TLDR
Overall, utilizing the VNantiplatelet function testing did not significantly change the clinical outcome after the NI procedures and larger randomized trials are warranted to provide a better understanding of the utility of the antiplatelet testing in NI stenting procedures.
Platelet function testing: does a randomized controlled trial settle the debate?
TLDR
This open-label RCT was designed to assess the effect of a modified antiplatelet regime compared with a standard preparation in NI patients with HTPR identified using PFTs and found the primary outcome of early peri-procedural thromboembolic complications were lower in the modified treatment group.
Preinterventional Clopidogrel Response Variability for Coil Embolization of Intracranial Aneurysms: Clinical Implications
BACKGROUND AND PURPOSE: Thromboembolism is one of the most serious complications in coil embolization for intracranial aneurysms, and antiplatelet premedication may reduce this complication. However,
Clopidogrel Resistance Is Associated with Thromboembolic Complications in Patients Undergoing Neurovascular Stenting
TLDR
Clopidogrel resistance was associated with increased periprocedural thromboembolic complications from neurovascular stent-placement procedures and Targeting the clopIDogrel dose to platelet inhibition assays may improve clinical outcomes and requires further study.
Relationship between low response to clopidogrel and periprocedural ischemic events with coil embolization for intracranial aneurysms
TLDR
Low response to clopidogrel had little effect on clinical outcome although it increased asymptomatic large ischemic lesions in this cohort.
Antiplatelet testing in neurointervention: we cannot ignore the signs
TLDR
This issue remains the Achilles’ heel of determining the consequences of inadequate platelet inhibition and, many would argue, poses more questions than answers.
...
1
2
3
4
...